Last reviewed · How we verify

Oxytocin + misoprostol — Competitive Intelligence Brief

Oxytocin + misoprostol (Oxytocin + misoprostol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Uterotonic agents. Area: Obstetrics.

marketed Uterotonic agents Oxytocin receptor; prostaglandin E1 receptor (EP receptor) Obstetrics Small molecule Live · refreshed every 30 min

Target snapshot

Oxytocin + misoprostol (Oxytocin + misoprostol) — Ain Shams Maternity Hospital. Oxytocin stimulates uterine contractions while misoprostol enhances uterine sensitivity and contractility to promote labor induction or augmentation and reduce postpartum hemorrhage.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Oxytocin + misoprostol TARGET Oxytocin + misoprostol Ain Shams Maternity Hospital marketed Uterotonic agents Oxytocin receptor; prostaglandin E1 receptor (EP receptor)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Uterotonic agents class)

  1. Ain Shams Maternity Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oxytocin + misoprostol — Competitive Intelligence Brief. https://druglandscape.com/ci/oxytocin-misoprostol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: